Free Trial

EGB/GILT

BOND SUMMARY

Markets have shifted to a risk-off position following escalating no-deal Brexit warnings and news that European drugmakers will delay the rollout of a Covid vaccine.

  • Gilts are leading the charge among European majors. Yields are 2-6bp lower on the day with the longer end of the curve outperforming.
  • The bund curve has similarly bull flattened with the 2s30s spread 4bp narrower.
  • OATs slightly underperform bunds at the longer end. Last yields: 2-year -0.7332%, 5-year -0.7166%, 10-year -0.387%, 30-year 0.3029%.
  • BTPs have given up much of the early gains and now trade close to unch on the day.
  • Sanofi and GSK have delayed their rollout of a Covid vaccine after stating that it failed to deliver a strong immune response in the elderly.
  • European Commission President Ursula Von der Leyen has warned that the probability of a no-deal Brexit is now higher than securing a deal. While both sides continue to talk up their commitment to reach an agreement, both have also ratcheted up warnings of a no-deal risk.
  • Belgium sold E350mn of the 0.80% Jun-25 OLO and GBP150mn of the Jun-26 OLO via the Optional Reserve Inquiry (ORI) facility.
  • The final German CPI print for November matched the initial estimate (-0.7% Y/Y). Spanish inflation was a touch better than expected (-0.8% vs -0.9% survey).

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.